Literature DB >> 11328789

Efficacy of gatifloxacin alone and in combination with cefepime against penicillin-resistant Streptococcus pneumoniae in a rabbit meningitis model and in vitro.

M Perrig1, F Acosta, M Cottagnoud, C M Gerber, M G Täuber, P Cottagnoud.   

Abstract

Gatifloxacin penetrated well into cerebrospinal fluid (CSF) (49 +/- 11%), measured by comparison of AUC(CSF)/AUC(serum), and showed good bactericidal activity (leading to a decrease of 0.75 +/- 0.17 log10 cfu/mL/h) in the treatment of experimental meningitis in rabbits caused by a penicillin-resistant pneumococcal strain (MIC 4 mg/L). It was significantly more effective than the standard regimen, ceftriaxone with vancomycin, which led to a decrease of 0.53 +/- 0.17 log10 cfu/mL/h. The addition of cefepime to gatifloxacin slightly improved the killing rates (giving a decrease of 0.84 +/- 0.14 log10 cfu/mL/h). In vitro, synergy was demonstrated between cefepime and gatifloxacin by the chequerboard method (fractional inhibitory concentration index = 0.5) and by viable counts over 8 h.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11328789     DOI: 10.1093/jac/47.5.701

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

1.  Acute-phase response alters the disposition kinetics of cefepime following intravenous administration to rabbits.

Authors:  A M Abd El-Aty; A Goudah; S M Mouneir; Y E Sunwoo; J H Jang; J G Shin; J H Shim; M Shimoda
Journal:  Vet Res Commun       Date:  2006-12-20       Impact factor: 2.459

2.  Fluoroquinolones in the Treatment of Meningitis.

Authors:  Philippe Cottagnoud; Martin G. Täuber
Journal:  Curr Infect Dis Rep       Date:  2003-08       Impact factor: 3.725

3.  Vancomycin acts synergistically with gentamicin against penicillin-resistant pneumococci by increasing the intracellular penetration of gentamicin.

Authors:  P Cottagnoud; M Cottagnoud; M G Täuber
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

4.  Gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis: safety, efficacy and patient perspective.

Authors:  Clyde Schultz
Journal:  Ophthalmol Eye Dis       Date:  2012-07-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.